UK extends special roles of primary care:
This article was originally published in Clinica
Executive Summary
The UK Department of Health has gone a step further in encouraging the primary care sector to extend the range of diagnostic and therapeutic activities it performs, with the publication yesterday (April 24 2003) of guidance on how general practitioners and nurses can take on extended roles. A guide for GPs with special interests (GPSI) covers 10 topics, including endoscopy, emergency care, respiratory disease and sexual health. This GPSI programme, launched in 2002, already covers other areas of care, including orthopaedics, cardiology, diabetes and urology. A separate guide for nurses covers areas such as heart failure and diabetes. By 2004, some 1,000 GPs are expected to take on special interest roles; some 650 GPs have already done so. At the end of 2001, some 600,000 procedures formerly carried out in hospitals were performed by primary care staff.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.